American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

Naji Gehchan, MD, MBA, the chief medical and development officer of Kyverna

Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis

November 5th 2025

Naji Gehchan, MD, MBA, the chief medical and development officer of Kyverna Therapeutics, went over new data the company presented at AANEM’s 2025 meeting.

Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis

ByNaji Gehchan, MD, MBA,Noah Stansfield

October 31st 2025

The chief medical and development officer of Kyverna Therapeutics went over new data the company presented at AANEM’s 2025 meeting.

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis

Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis

Trending on CGTlive®

Colleen Caleshu, MS, CGC, on Whether AI Will Replace Genetic Counselors